DE111 Probiotic Provides Benefits for Body Fat Percentage and Athletic Performance

Researchers have found that consumption of the probiotic strain DE111® in conjunction with adequate post-workout nutrition can improve body composition and indices of athletic performance during offseason training in collegiate athletes.

June 6, 2017

2 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

Press Release

Researchers have found that consumption of the probiotic strain DE111® in conjunction with adequate post-workout nutrition can improve body composition and indices of athletic performance during offseason training in collegiate athletes.

The study found that compared to the placebo, the probiotic DE111 produced statistically significantly improvements in the reduction of body fat percentage, and a strong trend indicating improved performance of the deadlift exercise. “These findings are encouraging for athletic individuals, both professional and recreational, that are looking for ways to naturally achieve maximum results from their training efforts,” said Dr. John Deaton, vice president of science and technology at Deerland Enzymes and Probiotics.

Twenty-three collegiate female athletes participated in the double-blind, randomized, placebo-controlled study. The athletes completed the same 10-week resistance training program during the offseason, which consisted of 3-4 workouts per week of upper and lower-body exercises and sport-specific training. The athletes consumed a DE111 or placebo supplement in conjunction with a recovery protein drink immediately following resistance and sport-specific training for the entire 10-week program.

Dr. Jeremy Townsend of Lipscomb University will present data from the study, “The effect of probiotic supplementation on body composition, muscle thickness, and athletic performance in Division I collegiate athletes” at the International Society of Sport Nutrition (ISSN) Annual Conference in Phoenix on June 22-24.

Deerland Enzymes & Probiotics provided support and the probiotic for the study.

DE111 is a genome sequenced and clinically tested strain of Bacillus subtilis, a probiotic spore that supports digestive and immune health. The genome sequencing confirmed the strain contained no plasmids, antibiotic resistant or deleterious genes; the human clinical studies showed the strain’s ability to control microbial populations, aid in digestion and maintain general health. DE111 has the ability to form spores that protect the microbes from harsh conditions until they enter an environment ripe for germination, such as the GI tract.  Because of this spore-forming ability, DE111 remains viable under a wide temperature and pH range, making it ideal for use in supplements as well as food and beverages.

Deerland Enzymes & Probiotics, based in Kennesaw, Ga., specializes in customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and often proprietary solutions. In addition to customized formulations, the company offers a line of university and clinically studied branded products. Deerland provides regulatory support and also performs specialty contract manufacturing services, including bulk blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling. To contact Deerland Enzymes & Probiotics, call 800.697.8179 or visit www.DeerlandEnzymes.com.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like